After finding it to be of “substandard quantity”, Nepal's Department of Drug Administration on Wednesday reportedly ordered Patanjali Ayurved to recall six of its medical products. There has been no correspondence from Patanjali in this regard. Notably, a reply to recent RTI in India revealed that nearly 40% of Ayurveda products, including items from Patanjali, were of substandard quality.
By Vikraman Maniraj | Jun 22, 2017 12:30 PM #PatanjaliProducts #SubstandardQuality
OTHER NEWS SHOTS
Read More News Stories